Y-Intercept (HK)’s BioXcel Therapeutics BTAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-4,683
Closed -$95.9K 1334
2024
Q2
$95.9K Buy
+4,683
New +$95.9K 0.01% 1262
2023
Q4
Sell
-1,722
Closed -$69.7K 1255
2023
Q3
$69.7K Buy
+1,722
New +$69.7K 0.01% 985